Trade Summary

4 months ago, Patel Snehal, serving as CEO, CFO, 10% owner at Greenwich Lifesciences, Inc. (GLSI), purchased 1,800 shares at $29.83 per share, for a total transaction value of $53,694.00. Following this transaction, Patel Snehal now holds 5,604,102 shares of GLSI.

The trade was executed on Tuesday, January 13, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, January 15, 2026 at 1:05 AM ET, 2 days after the trade was made.

Greenwich Lifesciences, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.